Aurologistic Llc,(auromedics Pharma Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Aurologistic Llc,(auromedics Pharma Pharmaceutical Import Records from India — 3 Products, $6.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aurologistic Llc,(auromedics Pharma — Pharmaceutical Importer Profile (2026) | 3 Products, $6.0M Trade | TransData Nexus

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sodium	Nutritional Supplements	$3.4M	68	0.9%	6
2	Pantoprazole	Gastrointestinal	$2.3M	46	0.2%	10
3	Piperacillin	Advanced Antibiotics	$350.0K	7	0.4%	12

Aurologistic Llc,(auromedics Pharma imports 3 pharmaceutical products across 3 categories into United States totaling $6.0M.

Aurologistic Llc,(auromedics Pharma — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Aurologistic LLC, operating under the trade name Auromedics Pharma, is a pharmaceutical importer and buyer based in the United States. The company specializes in sourcing finished pharmaceutical formulations—including tablets, capsules, syrups, and injections—from India. Headquartered in East Windsor, New Jersey, Auromedics Pharma plays a pivotal role in the U.S. pharmaceutical distribution network by facilitating the importation and distribution of these formulations to various stakeholders within the healthcare sector.

As a dedicated importer, Auromedics Pharma focuses exclusively on finished dosage forms, ensuring that the products meet the stringent regulatory standards required for sale and distribution in the U.S. market. This specialization allows the company to maintain a streamlined supply chain, emphasizing quality control and compliance with U.S. Food and Drug Administration (FDA) regulations. By sourcing products from India, Auromedics Pharma leverages the country's robust pharmaceutical manufacturing capabilities, which are recognized for producing high-quality generics that are both cost-effective and reliable.

2Distribution Network

Auromedics Pharma's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across the United States. While specific warehouse locations are not publicly disclosed, the company operates from its headquarters in East Windsor, New Jersey, positioning itself advantageously for nationwide distribution. The logistics capabilities are tailored to handle the complexities of pharmaceutical imports, including compliance with FDA regulations, temperature-controlled storage requirements, and timely delivery schedules. This infrastructure supports the company's commitment to maintaining the integrity and quality of the imported products throughout the distribution process.

Geographically, Auromedics Pharma's coverage spans the entire U.S., ensuring that healthcare providers, pharmacies, and hospitals have access to the imported formulations. The company's logistics operations are designed to accommodate the diverse needs of the U.S. healthcare system, including bulk shipments to large institutions and smaller deliveries to regional pharmacies. By maintaining a flexible and responsive distribution network, Auromedics Pharma effectively meets the demands of the U.S. pharmaceutical market.

3Industry Role

In the U.S. pharmaceutical supply chain, Auromedics Pharma functions primarily as a pharmaceutical importer and distributor. The company sources finished pharmaceutical formulations from Indian manufacturers and imports them into the United States, where they are distributed to various healthcare providers, including hospitals, clinics, and pharmacies. This role is crucial in ensuring the availability of cost-effective and high-quality generic medications within the U.S. market.

By focusing on finished dosage forms, Auromedics Pharma differentiates itself from other entities that may import raw active pharmaceutical ingredients (APIs) or bulk drugs. This specialization allows the company to concentrate on the complexities associated with the importation and distribution of ready-to-use pharmaceutical products, including compliance with FDA regulations, quality assurance, and logistical coordination. Through this dedicated approach, Auromedics Pharma contributes to the diversification and stability of the U.S. pharmaceutical supply chain, offering healthcare providers access to a broader range of therapeutic options.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Aurologistic Llc,(auromedics Pharma

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Auromedics Pharma's sourcing strategy is characterized by a significant concentration on a limited number of products imported from India. The company's total import value from India amounts to $6.0 million USD, encompassing 121 shipments of three distinct products across three therapeutic categories. This indicates a focused approach to product selection, potentially streamlining operations and quality control processes.

The top three products imported are Sodium ($3.4 million, Rank #6, 0.9% share), Pantoprazole ($2.3 million, Rank #10, 0.2% share), and Piperacillin ($350,000, Rank #12, 0.4% share). These products fall into the therapeutic categories of Nutritional Supplements (56.2%), Gastrointestinal (38.0%), and Advanced Antibiotics (5.8%), respectively. The high concentration on these specific products suggests a strategic choice to focus on areas with established demand and expertise.

While this sourcing concentration may offer operational efficiencies, it also presents potential risks. Dependence on a narrow product range could expose Auromedics Pharma to market fluctuations and regulatory changes affecting these specific products. Additionally, any supply chain disruptions with Indian manufacturers could significantly impact the company's ability to meet U.S. market demands. Therefore, it is essential for Auromedics Pharma to continuously assess and manage these risks to maintain a resilient and responsive supply chain.

2Supply Chain Resilience

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, approval, and distribution of pharmaceutical products. The FDA enforces a comprehensive framework of regulations designed to ensure the safety, efficacy, and quality of drugs available in the U.S. market.

Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act (FDCA), which provides the legal foundation for the FDA's authority over drug products. The Drug Approval Process, as outlined by the FDA, involves rigorous evaluation of clinical data, manufacturing practices, and labeling to ensure compliance with established standards. For foreign manufacturers, including those in India, obtaining FDA approval is a critical step in entering the U.S. market, necessitating adherence to FDA guidelines and inspections.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. Foreign manufacturers must register their facilities with the FDA and obtain an Establishment Registration number. Additionally, they must list their drug products with the FDA, providing detailed information about each product's composition, labeling, and intended use. Compliance with Good Manufacturing Practices (GMP) is mandatory, ensuring that products are consistently produced and controlled according to quality standards.

Aurologistic Llc,(auromedics Pharma — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Auromedics Pharma's product strategy focuses on three primary therapeutic areas: Nutritional Supplements (56.2%), Gastrointestinal (38.0%), and Advanced Antibiotics (5.8%). This strategic focus aligns with market demands for essential medications in these categories, addressing prevalent

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Aurologistic Llc,(auromedics Pharma

What products does Aurologistic Llc,(auromedics Pharma import from India?

Aurologistic Llc,(auromedics Pharma imports 3 pharmaceutical products across 3 categories. Top imports: Sodium ($3.4M), Pantoprazole ($2.3M), Piperacillin ($350.0K).

What is Aurologistic Llc,(auromedics Pharma's total pharmaceutical import value?

Aurologistic Llc,(auromedics Pharma's total pharmaceutical import value from India is $6.0M, based on 121 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Aurologistic Llc,(auromedics Pharma focus on?

Aurologistic Llc,(auromedics Pharma imports across 3 categories. The largest: Nutritional Supplements (56.2%), Gastrointestinal (38.0%), Advanced Antibiotics (5.8%).

Get Full Aurologistic Llc,(auromedics Pharma Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Aurologistic Llc,(auromedics Pharma

Aurologistic Llc,(auromedics Pharma — Import Portfolio & Supplier Network

What Products Does Aurologistic Llc,(auromedics Pharma Import?

Top Products by Import Value

Aurologistic Llc,(auromedics Pharma Therapeutic Categories — 3 Specializations